Celanese Corporation (NYSE:CE), a global technology and specialty
materials company, today announced the introduction of Hostaform® MT®
SlideX™ POM, a family of tribologically modified, medically compliant
engineered materials.
These new thermoplastic polymers enable the production of medical
devices with a very low coefficient of friction and wear, low noise
(squeaking) and eliminate the need for external lubrication. Medical
devices manufactured with these new materials operate smoothly with a
high degree of patient comfort and consistency from the very first use.
Hostaform® MT® SlideX™ POM is a competitive alternative to various kinds
of high-performance, tribologically modified compounds. When compared to
alternative materials, Hostaform® MT® SlideX™ POM offers a significantly
lower coefficient of friction in medical devices combined with the
Celanese medical technology (MT®) service package. This results in the
potential to reduce costs by removing design constraints and simplifying
material combinations in complex devices while avoiding external
lubrication in manufacturing processes.
The MT® service package addresses quality, change control and regulatory
compliance in accordance with pharmaceutical and medical industry
expectations, based on Celanese’s extensive experience with material
supply to the medical market.
The advantages to the patient as a result of medical device
manufacturers using Celanese’s tribologically modified Hostaform® MT®
SlideX™ POM include:
-
reduction in force required to activate the medical device,
-
no squeaking noise when operating the medical device, and
-
increased comfort during use due to easy sliding properties.
“The use of medically compliant polymers from Celanese is helping the
medical industry to design and manufacture medical devices which can
significantly increase patient comfort by reducing friction and noise,”
said Andrew Brown, director of Celanese’s global medical industry
platform. “These new materials can improve design and processing
capability and increase performance levels of key medical components.
The introduction of these new low-tribological polymer grades from
Celanese underscores our commitment to medical industry innovation which
benefits patients who seek greater comfort and ease of use in their
medical devices.”
With a high mechanical performance profile combined with the Celanese
MT® service package, Hostaform® MT® SlideX™ POM is well-suited for
medical applications such as COPD (Chronic Obstructive Pulmonary
Disease) and asthma inhalers, injection devices such as insulin pens,
surgical instruments and portable diagnostic medical devices, where low
friction, wear and medical compliance are important requirements.
About Celanese Hostaform® / Celcon POM
Celanese’s Hostaform® / Celcon® POM materials deliver outstanding wear,
long-term fatigue and creep resistance from -40°C to 100°C and exhibit
excellent toughness and rigidity, along with moisture, solvent and
alkali resistance.
For more information, reference the Celanese Hostaform®
/ Celcon® POM website.
About Celanese
Celanese Corporation is a global technology leader in the production
of differentiated chemistry solutions and specialty materials used in
most major industries and consumer applications. With sales almost
equally divided between North America, Europe and Asia, the company uses
the full breadth of its global chemistry, technology and business
expertise to create value for customers and the corporation. Celanese
partners with customers to solve their most critical needs while making
a positive impact on its communities and the world. Based in Dallas,
Texas, Celanese employs approximately 7,400 employees worldwide and had
2013 net sales of $6.5 billion. For more information about Celanese
Corporation and its product offerings, visit www.celanese.com
or our blog at www.celaneseblog.com.
All registered trademarks are owned by Celanese International
Corporation or its affiliates.
News Release
Forward-Looking Statements
This release may contain “forward-looking statements,” which include
information concerning the company's plans, objectives, goals,
strategies, future revenues or performance, and other information that
is not historical information. When used in this release, the words
“outlook,” “forecast,” “estimates,” “expects,” “anticipates,”
“projects,” “plans,” “intends,” “believes,” “may,” “can,” “could,”
“might,” “will” and variations of such words or similar expressions are
intended to identify forward-looking statements. All forward-looking
statements are based upon current expectations and beliefs and various
assumptions. There can be no assurance that the company will realize
these expectations or that these beliefs will prove correct. There are a
number of risks and uncertainties that could cause actual results to
differ materially from the results expressed or implied in the
forward-looking statements contained in this release. These risks and
uncertainties include, among other things: changes in general economic,
business, political and regulatory conditions; changes in the price and
availability of raw materials; the ability to improve productivity by
implementing technological improvements; increased price competition and
the introduction of competing products by other companies; market
acceptance of our technology; the ability to obtain governmental
approvals and to construct facilities on terms and schedules acceptable
to the company; unavailability of required materials and equipment;
unanticipated operational or commercial difficulties, including failure
of facilities or processes to operate in accordance with specifications
or expectations; the ability to achieve and maintain plant
utilization; ability of third parties, including our commercial
partners, suppliers or others, to comply with their commitments to us;
the cost or availability of capital necessary to fund plant
construction; changes in the degree of intellectual property and other
legal protection afforded to our products or technology, or the theft of
such intellectual property; compliance and other costs and potential
disruption or interruption of production or operations due to accidents,
cyber security incidents, terrorism or political unrest or other
unforeseen events or delays in construction or operation of facilities,
including the occurrence of acts of war or terrorist incidents or as a
result of weather or natural disasters; potential liability for remedial
actions and increased costs under existing or future environmental
regulations, including those relating to climate change; potential
liability resulting from pending or future litigation, or from changes
in the laws, regulations or policies of governments or other
governmental activities in the countries in which we operate; changes in
currency exchange rates and interest rates; and various other factors
discussed from time to time in the company's filings with the Securities
and Exchange Commission. Any forward-looking statement speaks only as of
the date on which it is made, and the company undertakes no obligation
to update any forward-looking statements to reflect events or
circumstances after the date on which it is made or to reflect the
occurrence of anticipated or unanticipated events or circumstances.
Editor’s Note:
Tribological interactions: The tribological interactions of a solid
surface's exposed face with interfacing materials and the environment
may result in loss of material from the surface. The process leading to
loss of material is known as "wear." Major types of wear include abrasion,
adhesion,
surface fatigue and tribochemical reaction (i.e., corrosion).
Wear can be minimized by modifying the surface properties of solids by
one or more of "surface
engineering" processes (also called surface
finishing) or by use of internal and external lubricants.
Copyright Business Wire 2014